Evaluation of the Accuracy of the Vessel Navigator Tool for Catheterization of Supra-aortic Vessels - ARCHIBALD
ARCHIBALD
1 other identifier
observational
15
1 country
1
Brief Summary
This study compares the accuracy of fusion imaging (Fusion Roadmap) versus real-time X-ray imaging (Roadmap) during catheterization of supra-aortic trunks of in patients with aneurysms or arteriovenous malformations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2017
CompletedFirst Posted
Study publicly available on registry
September 1, 2017
CompletedStudy Start
First participant enrolled
December 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedMarch 26, 2019
December 1, 2017
Same day
August 30, 2017
March 25, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Offset (in mm) between the lateral edge of the opacified artery and that visualized with the fusion imaging.
Measurement will be performed 1 cm above each ostium. There will be 4 measurements per patient (4 vessels analyzed).
baseline
Secondary Outcomes (1)
Subjective opinion of the second operator on the aspect of registration to carry out the catheterization (satisfactory or not).
baseline
Eligibility Criteria
Patients with preoperative assessment or systematic follow-up of aneurysms or arteriovenous malformations, arterial cervical or intracranial stenosis, head and neck vascular tumors.
You may qualify if:
- Preoperative assessment or systematic follow-up of aneurysms or arteriovenous malformations, arterial cervical or intracranial stenosis, head and neck vascular tumors.
You may not qualify if:
- Patients with contraindication to intravenous contrast.
- Patients with catheterization of the supra-aortic vessels in an emergency settings (Stroke, acute bleeding)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondation Opthalmologique A de Rothschild
Paris, 75019, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raphaël BLANC, MD
Fondation ophtalmologique de Rothschild
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 30, 2017
First Posted
September 1, 2017
Study Start
December 1, 2018
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
March 26, 2019
Record last verified: 2017-12